Procedures & recovery · patient guide

How is psoriasis treated in China?

Psoriasis treatment in China follows the same broad principles used internationally: a dermatologist confirms the diagnosis and severity, then discusses topical therapy, phototherapy, conventional systemic medicines or biologic drugs according to the type of psoriasis, its extent, the joints involved and the patient's other health conditions. Overseas patients should expect an in-person assessment in China before any prescription, because treatment choice depends on examination and test results that a records review alone cannot supply.

Go to the practical guidance ↓
AI illustration: A woman in a beige blazer reading documents at a desk with notebooks, a pen, and potted plants in a bright office.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a Chinese dermatology assessment actually involves

Psoriasis is a chronic inflammatory skin condition, and no responsible clinician chooses a long-term treatment from a photograph or a diagnosis label alone. At a first specialist visit in China, the dermatologist will typically look at the affected skin and scalp, ask how long the problem has lasted, what has been tried and how the patient responded, and ask about itching, pain and how much the condition affects sleep, work and daily life. Psoriasis severity is judged partly by how much body surface is involved and partly by location: limited patches on the elbows may be manageable with creams, while involvement of the face, hands, feet, genital area or nails can matter far more than the percentage of skin affected.

The clinician will also ask about joint pain and stiffness. Psoriatic arthritis is a recognised complication of psoriasis, and a patient with swollen or painful joints may need assessment beyond the skin. Other questions usually cover recent infections, tuberculosis exposure, liver and kidney problems, pregnancy plans, and any medicines already in use. These are not box-ticking formalities: several systemic and biologic treatments require screening for infections and blood or organ problems before they can be considered safely.

For an overseas patient, the practical consequence is that the first visit is an assessment, not a guaranteed prescription. The dermatologist decides whether the diagnosis is clear, whether a skin biopsy is needed to exclude another condition, and which baseline tests are appropriate. Those decisions belong to the treating clinician, and the patient should ask directly what will be checked, why, and when the results are expected.

The main treatment routes and how they are chosen

Chinese dermatology practice draws on the same categories of treatment used elsewhere. Topical treatments such as corticosteroids, vitamin D analogues and other preparations are the usual starting point for limited plaque psoriasis. Phototherapy, including narrowband ultraviolet B, is used for more extensive skin involvement under supervised protocols. Conventional systemic medicines, including methotrexate, ciclosporin and acitretin, are used for moderate to severe disease or when topicals and light treatment are insufficient. Biologic drugs that target specific steps in the inflammatory pathway are used for selected patients with moderate to severe psoriasis, and some are also used for psoriatic arthritis.

The choice among these routes is not a matter of patient preference alone. It depends on the type of psoriasis, how extensive and how active it is, whether joints are involved, what has already failed, and what the patient's general health and infection risk allow. A patient who has already tried several systemic medicines is in a different position from someone newly diagnosed with a few plaques. So is a patient with significant joint symptoms, who may need a rheumatology opinion alongside dermatology.

Patients should also understand that psoriasis treatment is generally long-term management rather than a single course that ends the condition. The aim is to control inflammation, reduce symptoms, protect joints where relevant and limit the impact on daily life. Any clinician who promises a permanent cure should be treated with caution. Conversely, a realistic plan usually includes review points, because response and tolerance are judged over time and the plan may be adjusted.

Records that make an overseas consultation more useful

A Chinese dermatologist meeting an international patient for the first time benefits from a clear history rather than a large unsorted file. The most useful items are the original diagnosis and when it was made, a list of treatments already used with doses, duration and response, and any record of adverse effects or reasons for stopping. Photographs taken over time can help show how the condition has changed, especially if the skin looks different on the day of the visit. Blood test results, infection screening and any imaging of painful joints are relevant if systemic or biologic treatment is being considered.

Patients should also bring a current medication list, including medicines for other conditions, and a short summary of allergies and past serious infections. If the patient has been seen by a rheumatologist for joint symptoms, that correspondence is worth including. Records do not need to be translated into Chinese in advance for an initial enquiry, but the patient should ask what language support the chosen hospital can provide for the consultation itself and for written instructions afterwards.

One caution is worth stating plainly: a records-based opinion can discuss options and identify missing information, but it cannot confirm that a particular medicine is appropriate or available for this patient. That judgement requires the in-person examination and the tests the treating team considers necessary. Patients should not stop or change any current psoriasis medicine while planning a trip; any change should be discussed with the prescriber.

Safety questions specific to psoriasis care in China

The safety of psoriasis treatment depends far more on the clinical process than on the country. The questions worth asking are the same ones a careful patient would ask anywhere. Who will supervise the treatment and how will response be monitored? Which blood tests or infection screening are required before starting, and how often afterwards? What symptoms should prompt an urgent call, and how can an overseas patient reach the treating team between visits? For phototherapy, how are doses calculated and recorded? For biologic treatment, what happens if a dose is missed or delayed?

Patients considering care in China should also ask how continuity will work after they return home. Long-term psoriasis treatment usually needs ongoing review, and a plan that cannot be continued or monitored locally may not be practical. It is reasonable to ask the treating team what written summary they can provide for the patient's own dermatologist, and whether they are willing to discuss the plan with that clinician. The receiving clinician at home makes their own judgement about continuing any treatment.

Cost is a separate question from safety, and patients should ask the hospital what a proposed plan includes rather than relying on general impressions. A written quote or treatment plan should be requested for the specific medicines, tests and reviews proposed. ChinaSpecialistCare's coordination fees are separate from hospital charges, and the hospital confirms its own fees.

Traditional Chinese medicine alongside conventional care

Some international patients ask whether traditional Chinese medicine has a role in psoriasis. This is a reasonable question to raise with the treating dermatologist, but it should be framed carefully. Psoriasis is an immune-mediated condition, and herbal preparations are not a substitute for assessment of severity, joint involvement or the need for systemic treatment. Some herbal products can interact with other medicines or affect the liver, so a clinician managing the patient's conventional treatment should know about anything being taken.

A traditional Chinese medicine consultation route can be planned as an individual consultation for long-term concerns, with qualified clinicians assessing suitability alongside existing care. It is an enquiry topic, not a claim that herbal treatment cures psoriasis or replaces prescribed therapy. Patients should not stop prescribed treatment in order to try an alternative approach, and they should ask any practitioner about the evidence for the specific preparation proposed, its known risks and how it might interact with their current medicines.

The practical position is that conventional dermatology assessment comes first, and any complementary approach is discussed openly with the treating team rather than arranged in parallel without their knowledge.

How to take the next step without overcommitting

An overseas patient planning psoriasis care in China does not need to buy a proxy consultation or commit to treatment before speaking to anyone. A sensible first step is a short enquiry describing the diagnosis, the main current problem, the treatments already tried and the specific question the patient wants answered. ChinaSpecialistCare's team can check what information is available, identify obvious gaps and suggest a relevant next step; this is not a diagnosis and does not promise that a hospital will accept the case.

If the patient decides to travel, specialist matching and appointment coordination can help arrange a dermatology consultation at a suitable hospital, with the patient's records prepared in advance. Hospital consultation fees and any treatment costs are separate from coordination fees, and the treating hospital decides suitability and the treatment plan. Patients should confirm the appointment, the language arrangements and what to bring before making travel commitments, and should keep their current treatment unchanged until a clinician advises otherwise.

The most useful thing a patient can do now is to gather the diagnosis, treatment history and recent test results, write down two or three specific questions, and ask for a written summary of what any proposed plan would involve.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. traditional Chinese medicine
  2. NHS: Psoriasis
  3. National Institute for Health and Care Excellence: Psoriasis — assessment and management

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.